In This Article:
JPMorgan lowered the firm’s price target on NOV Inc. (NOV) to $17 from $20 and keeps an Overweight rating on the shares. Despite a Q1 beat that featured strong free cash flow conversion, NOV shares dropped, reflecting a softer Q2 outlook and full-year guidance reduction relative to consensus expectations, the analyst tells investors in a research note. The firm believes NOV continued to dispel some concerns around offshore trends in the deepwater.
Protect Your Portfolio Against Market Uncertainty
-
Discover companies with rock-solid fundamentals in TipRanks' Smart Value Newsletter.
-
Receive undervalued stocks, resilient to market uncertainty, delivered straight to your inbox.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on NOV: